COVID-19: WHO approves emergency use of China s Sinopharm COVID-19 vaccine ANI | Updated: May 08, 2021 02:41 IST
Geneva [Switzerland], May 8 (ANI): The World Health Organisation (WHO) on Friday approved the Chinese SinopharmCOVID-19 vaccine for emergency use, paving the way for it to be rolled out globally.
The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, a subsidiary of China National Biotec Group (CNBG). The addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk, said Dr Mariangela Simao, WHO Assistant-Director General for Access to Health Products, in a statement.
Advertisement
“In the case of the Sinopharm vaccine, the WHO assessment included on-site inspections of the production facility. The Sinopharm product is an inactivated vaccine called SARS-CoV-2 Vaccine (Vero Cell). Its easy storage requirements make it highly suitable for low-resource settings. It is the also first vaccine that will carry a vaccine vial monitor, a small sticker on the vaccine vials that change color as the vaccine is exposed to heat, letting health workers know whether the vaccine can be safely used.
“WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) has also completed its review of the vaccine. On the basis of all available evidence, WHO recommends the vaccine for adults 18 years and older, in a two-dose schedule with a spacing of three to four weeks. Vaccine efficacy for symptomatic and hospitalised disease was estimated to be 79%, all age groups combined.
WHO approves China s Sinopharm Covid-19 vaccine for emergency use, has 79% efficacy
WHO approves China s Sinopharm Covid-19 vaccine for emergency use, has 79% efficacy
The World Health Organisation has approved China s Sinopharm Covid-19 vaccine for emergency use. The vaccine has an overall efficacy of 79per cent against the disease.
advertisement
UPDATED: May 8, 2021 02:08 IST
Sinopharm (above) is the first Chinese Covid-19 vaccine to get WHO s nod for emergency use. (Photo: AFP)
In a big relief for China, the World Health Organisation (WHO) on Friday finally granted the conditional approval to its Sinopharm Covid-19 vaccine for emergency use, a move that could help Beijing step up its vaccine diplomacy amid the surge in coronavirus vaccines in several countries.
WHO Approves Chinese Counter Covid19 Vaccine For Emergency Use
Xinhua reported.
The World Health Organization has granted emergency approval for the Covid vaccine made by Chinese firm Sinopharm. It is the first vaccine developed in a non-Western country to get WHO backing. China has already vaccinated millions of people at home and in 45 other countries.
“This afternoon, WHO gave emergency use listing to Sinopharm Beijing’s COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a press briefing. “This expands the list of vaccines that COVAX can buy, and gives countries confidence to expedite their own regulatory approval, and to import and administer a vaccine.”
Kathmandu DHO temporarily suspends Covid-19 vaccination drive thehimalayantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehimalayantimes.com Daily Mail and Mail on Sunday newspapers.